Corrigendum to: “Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients” Stem Cell Res. 2018 May; 29:1–5
Year: 2019
Type: erratum
Abstract: The authors regret that the funding information was not properly included in the published version of the article. Credit for supporting the research included in the publication should be given to the Spanish Ministry for Science and Innovation (grant numbers PLE2009-0091, RTC-2014-2207-1 and IPT-2011-1402-900000); ISCIII PI14/01073, co-funded by ERDF/ESF Investing in your future; the Balearic Government (grant number 16023/2008); the Spanish Cystic Fibrosis Federation (Pablo Motos grant); Federacion ASEM-Telemaraton Todos somos raros, todos somos unicos; Fundacion Salud 2000; the European Commission, (H2020 grant number PHC-667079) and an endowment from METROVACESA. IML and AF were recipients of Juan de la Cierva postdoctoral fellowships from the Spanish Ministry for Science and Innovation (JCI-2009-05209 and JCI-2006-2675, respectively). VJA was a beneficiary of a co-funded contract from the Spanish Ministry for Science and Innovation (contract number: CA10/01371). VG and EP were recipients of predoctoral fellowships from the Balearic Government (FPI/CIMERA/2011 and FPI/FISIB/2013, respectively).
Source: Stem Cell Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,100
Awards: G1831617152, G2628364946, G3559709381, La Fibrosis Quística como modelo para la aplicación de terapias avanzadas al tratamiento de las enfermedades raras y su adaptación a la práctica clínica, G4937468798, Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters, G8824911526
OpenAlex ID: W2914221466